Viracta Therapeutics, Inc.: 10-Q filed 2013-08-02
What Viracta Therapeutics, Inc. reported in its quarterly report filed 2013-08-02 (fiscal Q2 2013): 31 published measures, 90 facts as tagged in accession 0001193125-13-317328.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-02
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001193125-13-317328 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Viracta Therapeutics, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 50,634,000 | USD | |
| At 2012-12-31 | 73,017,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -5,786,000 | USD | |
| At 2012-12-31 | 11,957,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 6,605,000 | USD | |
| At 2012-12-31 | 14,940,000 | USD | |
| At 2012-06-30 | 11,743,000 | USD | |
| At 2011-12-31 | 9,311,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -8,190,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -19,814,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -8,579,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -22,503,000 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -19,034,000 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -15,127,000 | USD | 182 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,989,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 3,978,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 1,500,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,500,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -2,564,000 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 461,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 13,263,000 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 17,098,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | -464,911,000 | USD | |
| At 2012-12-31 | -445,097,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 51,630,000 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 51,609,000 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 46,953,000 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 46,873,000 | shares | 182 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 53,268,000 | shares | 91 |
| 2013-01-01 to 2013-06-30 | 51,609,000 | shares | 181 |
| 2012-04-01 to 2012-06-30 | 47,286,000 | shares | 91 |
| 2012-01-01 to 2012-06-30 | 46,873,000 | shares | 182 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -0.16 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -0.38 | USD/shares | 181 |
| 2012-04-01 to 2012-06-30 | -0.18 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | -0.48 | USD/shares | 182 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -0.18 | USD/shares | 91 |
| 2013-01-01 to 2013-06-30 | -0.38 | USD/shares | 181 |
| 2012-04-01 to 2012-06-30 | -0.2 | USD/shares | 91 |
| 2012-01-01 to 2012-06-30 | -0.48 | USD/shares | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 31,000 | USD | |
| At 2012-12-31 | 43,000 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -8,574,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -16,406,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -8,754,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -17,589,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 50,580,000 | USD | |
| At 2012-12-31 | 72,932,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 768,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,599,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 316,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 631,000 | USD | 182 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 35,238,000 | USD | |
| At 2012-12-31 | 31,741,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 2,109,000 | USD | |
| At 2012-12-31 | 78,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 10,563,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 20,384,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 10,254,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 19,089,000 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 7,674,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 15,051,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 8,072,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 14,718,000 | USD | 182 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 38,000 | USD |
Long-term debt
Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 21,980,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 23,000 | USD | |
| At 2012-12-31 | 42,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 998,000 | USD | |
| At 2012-12-31 | 1,705,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -8,207,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -19,852,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -8,592,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -22,527,000 | USD | 182 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -8,190,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -19,814,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -8,579,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -22,503,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 2,889,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 5,333,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 2,182,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,371,000 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 12,000 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 16,000 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 1,152,000 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,809,000 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 491,000 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -4,283,000 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 2,031,000 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -265,000 | USD | 182 |
Inspect the source
- Entity
- Viracta Therapeutics, Inc. / CIK 0001061027
- Captured
- 2026-09-21T17:17:49.171Z
- SEC response SHA-256
46e1f007a1af4059ddd3a1b769d50f0b0415de87e9fba66a6561be1394613e67
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001061027.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))